BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2900036)

  • 1. Vasodilator response to dopamine in the ferret pulmonary circulation.
    Gorman P
    Br J Pharmacol; 1988 May; 94(1):212-8. PubMed ID: 2900036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional ontogeny of pulmonary vascular DA1 dopamine receptors in the isolated perfused rabbit lung.
    Polak MJ; Taylor DA
    Pediatr Res; 1994 Feb; 35(2):228-32. PubMed ID: 7909367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fenoldopam on preconstricted isolated salt-perfused rat lungs.
    Polak MJ; Knight ME; Gause GE; Bucciarelli RL; Drummond W
    J Appl Physiol (1985); 1989 Sep; 67(3):1076-80. PubMed ID: 2571605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of peripheral dopamine receptors by a selective DA1 antagonist, SCH 23390.
    Goldberg LI; Glock D; Kohli JD; Barnett A
    Hypertension; 1984; 6(2 Pt 2):I25-30. PubMed ID: 6144634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro.
    Edwards RM
    Eur J Pharmacol; 1986 Jul; 126(1-2):167-70. PubMed ID: 2875883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bulbocapnine is not a selective DA1 receptor antagonist.
    Kohli JD; Glock D; Goldberg LI
    J Pharm Pharmacol; 1986 May; 38(5):401-2. PubMed ID: 2872323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the vasodilator action of dopamine and dopamine agonists in the renal and coronary beds of the dog.
    Lang WJ; Woodman OL
    Br J Pharmacol; 1982 Sep; 77(1):23-8. PubMed ID: 6982091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel orally active dopamine (DA) prodrug TA-870. IV. Renal vasodilatory and negative chronotropic effects in anesthetized dogs: influence of DA1 and DA2 dopamine receptor selective antagonists.
    Nishiyama S; Yoshikawa M; Yamaguchi I
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):560-7. PubMed ID: 1711621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulation of dopamine receptors alters hypoxic pulmonary vasoconstriction in isolated perfused rat lungs.
    Polak MJ; Kennedy LA; Drummond WH
    Life Sci; 1992; 51(17):1317-23. PubMed ID: 1357520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DA1 receptor mediates dopamine-induced relaxation of opossum lower esophageal sphincter in vitro.
    Lombardi DM; Grous M; Fine CF; Barone FC; Fowler PJ; Phyall WB; Rush JA; Ormsbee HS
    Gastroenterology; 1986 Sep; 91(3):533-9. PubMed ID: 2874097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of selective dopamine DA1 and DA2 agonists and antagonists on experimental gastric lesions and gastric acid secretion.
    Glavin GB
    J Pharmacol Exp Ther; 1989 Nov; 251(2):726-30. PubMed ID: 2530341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.
    Dupont AG; Lefebvre RA; Vanderniepen P
    Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of selective dopamine receptor agonists in the rat and dog.
    Hieble JP; Owen DA; Harvey CA; Blumberg AL; Valocik RE; DeMarinis RM
    Clin Exp Hypertens A; 1987; 9(5-6):889-912. PubMed ID: 2887313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antagonism of D1-receptor-mediated vasodilator response in the perfused kidney by SCH23390.
    Martin SW; Broadley KJ
    Pharmacol Res; 1995 May; 31(5):289-97. PubMed ID: 7479526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of acute inhibition of Na/H exchanger NHE-3 by dopamine in opossum kidney cells.
    Wiederkehr MR; Di Sole F; Collazo R; QuiƱones H; Fan L; Murer H; Helmle-Kolb C; Moe OW
    Kidney Int; 2001 Jan; 59(1):197-209. PubMed ID: 11135072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog.
    Kopia GA; Valocik RE
    J Pharmacol Exp Ther; 1989 Jan; 248(1):215-21. PubMed ID: 2563287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the responses to some dopamine-receptor agonists and antagonists in the isolated perfused rat kidney.
    Woodman OL; Rechtman MP; Lang WJ
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):203-11. PubMed ID: 6971630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and renal vasodilator activity of 2-chlorodopamine and N-substituted derivatives.
    McCarthy JR; McCowan J; Zimmerman MB; Wenger MA; Emmert LW
    J Med Chem; 1986 Sep; 29(9):1586-90. PubMed ID: 3528490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibition of ganglionic transmission via presynaptic dopamine DA1 and postsynaptic DA2 receptor activation in the canine cardiac sympathetic ganglia.
    Mukai M; Kushiku K; Yamada H; Yamada K; Dan K; Furukawa T
    J Pharmacol Exp Ther; 1996 Nov; 279(2):822-9. PubMed ID: 8930189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.